Akeso Announces Summit Therapeutics and ECOG-ACRIN Cancer Research Group Enter into Phase II/III Clinical Trial Collaboration to Evaluate Ivonescimab in First-Line Biliary Tract Cancer Written by PR Newswire Enable JavaScript and cookies to continueRead more http://www.prnasia.com/story/archive/5077699_CN77699_0